Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-06-05
2000-08-08
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514 12, A61K 31135, A61K 3800
Patent
active
061003018
ABSTRACT:
The present invention provides novel methods of treating or preventing osteoporosis comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different provided that, when R.sup.1 and R.sup.2 are the same, each is a methyl or ethyl group, and, when R.sup.1 and R.sup.2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof; together with a bone resorption inhibiting polyphosphonate, or with parathyroid hormone.
REFERENCES:
patent: 5118886 (1992-06-01), Adam et al.
patent: 5462932 (1995-10-01), Brenner et al.
MacLean David B.
Thompson David D.
Djuardi Elsa
Ginsburg Paul H.
Goldberg Jerome D.
Pfizer Inc
Richardson Peter C.
LandOfFree
Combination therapy to treat osteoporosis-polyphosphonates and e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy to treat osteoporosis-polyphosphonates and e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy to treat osteoporosis-polyphosphonates and e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1150660